Frequent loss of imprinting of IGF2 and MEST in lung adenocarcinoma

Genomic imprinting is a parental origin–specific chromosomal modification that causes differential expression of maternal and paternal alleles of a gene. Accumulating evidence suggests that deregulation of imprinted genes, including loss of imprinting (LOI), plays a role in oncogenesis. In the present study, we investigated allelic expression of six imprinted genes in human lung adenocarcinomas as well as in matched normal lung tissue. Informative cases showing heterozygosity for the gene of interest were selected from 35 patients. LOI of the insulin‐like growth factor 2 gene (IGF2) and mesoderm‐specific transcript (MEST, also known as paternally expressed gene 1) was noted in 47% (seven of 15) and 85% (11 of 13) of informative cases, respectively. Monoallelic expression was maintained in all the matched normal tissues examined. LOI of IGF2 was seen more frequently in moderately to poorly differentiated adenocarcinomas. In contrast, H19, small nuclear ribonucleoprotein–associated polypeptide N gene (SNRPN), necdin gene (NDN), and long QT intronic transcript 1 (LIT1) exhibited consistent monoallelic expression in all the informative samples. These findings indicated that independent deregulation took place in imprinted genes and suggested that aberrant imprinting of IGF2 and MEST was involved in the development of lung adenocarcinoma. © 2001 Wiley‐Liss, Inc.

[1]  Mitsuo Oshimura,et al.  Loss of Imprinting of Long QT Intronic Transcript 1 in Colorectal Cancer , 2001, Oncology.

[2]  C. Plass,et al.  Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Meguro,et al.  Targeted disruption of the human LIT1 locus defines a putative imprinting control element playing an essential role in Beckwith-Wiedemann syndrome. , 2000, Human molecular genetics.

[4]  K. Mitsuya,et al.  Multipoint imprinting analysis in sporadic colorectal cancers with and without microsatellite instability. , 2000, International journal of oncology.

[5]  C. Croce,et al.  Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[6]  T. Mukai,et al.  An NsiI RFLP in the human long QT intronic transcript 1 (LIT1) , 2000, Journal of Human Genetics.

[7]  A. Hoffman,et al.  Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region. , 2000, Genomics.

[8]  B. Tycko,et al.  Epigenetic gene silencing in cancer. , 2000, The Journal of clinical investigation.

[9]  N. Miller,et al.  Frequent loss of imprinting of PEG1/MEST in invasive breast cancer. , 1999, Cancer research.

[10]  J. Issa,et al.  Aging, DNA methylation and cancer. , 1999, Critical reviews in oncology/hematology.

[11]  K. Ochi,et al.  High frequency of inactivation of the imprinted H19 gene in “sporadic” hepatoblastoma , 1999, International journal of cancer.

[12]  A. Feinberg,et al.  LIT1, an imprinted antisense RNA in the human KvLQT1 locus identified by screening for differentially expressed transcripts using monochromosomal hybrids. , 1999, Human molecular genetics.

[13]  A. Feinberg,et al.  Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Feinberg.  Imprinting of a genomic domain of 11p15 and loss of imprinting in cancer: an introduction. , 1999, Cancer research.

[15]  N. Niikawa,et al.  Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors. , 1998, American journal of medical genetics.

[16]  A. Feinberg,et al.  Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability , 1998, Nature Medicine.

[17]  M. Azim Surani,et al.  Abnormal maternal behaviour and growth retardation associated with loss of the imprinted gene Mest , 1998, Nature Genetics.

[18]  S. Saitoh,et al.  Imprinting in Prader-Willi and Angelman syndromes. , 1998, Trends in genetics : TIG.

[19]  Shirley M. Tilghman,et al.  Location of enhancers is essential for the imprinting of H19 and Igf2 genes , 1998, Nature.

[20]  T. Ishikawa,et al.  Loss of imprinting of igf2 in renal‐cell carcinomas , 1998, International journal of cancer.

[21]  N. Niikawa,et al.  Paternal expression of WT1 in human fibroblasts and lymphocytes. , 1997, Human molecular genetics.

[22]  D. Barlow.  Competition—a common motif for the imprinting mechanism? , 1997, The EMBO journal.

[23]  R. Wevrick,et al.  The necdin gene is deleted in Prader-Willi syndrome and is imprinted in human and mouse. , 1997, Human molecular genetics.

[24]  J. Kere,et al.  Monoallelic expression of human PEG1/MEST is paralleled by parent-specific methylation in fetuses. , 1997, Genomics.

[25]  O. Tsutsumi,et al.  Human PEG1/MEST, an imprinted gene on chromosome 7. , 1997, Human molecular genetics.

[26]  T. Ono,et al.  IGF2 but not H19 shows loss of imprinting in human glioma. , 1996, Cancer research.

[27]  L. Feng,et al.  Chromosome 11p15.5 regional imprinting: comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors. , 1996, Human molecular genetics.

[28]  S. Elledge,et al.  Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5. , 1996, Oncogene.

[29]  Katsuki Ito,et al.  Loss of H19 imprinting in esophageal cancer. , 1996, Cancer research.

[30]  M. Surani,et al.  Peg1/Mest imprinted gene on chromosome 6 identified by cDNA subtraction hybridization , 1995, Nature Genetics.

[31]  M. Pazin,et al.  An enhancer deletion affects both H19 and Igf2 expression. , 1995, Genes & development.

[32]  S. Tilghman,et al.  Disruption of imprinting caused by deletion of the H19 gene region in mice , 1995, Nature.

[33]  R. Ueda,et al.  Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. , 1995, Oncogene.

[34]  M. Koyama,et al.  Loss of imprinting in choriocarcinoma , 1995, Nature Genetics.

[35]  R. Ueda,et al.  Altered imprinting in lung cancer , 1994, Nature Genetics.

[36]  S. Leff,et al.  Maternal imprinting of human SNRPN, a gene deleted in Prader–Willi syndrome , 1994, Nature Genetics.

[37]  Benjamin Tycko,et al.  Tumour-suppressor activity of H19 RNA , 1993, Nature.

[38]  N. Bleehen,et al.  Expression of insulinlike growth factor (IGF) and IGF-binding protein genes in human lung tumor cell lines. , 1992, Journal of the National Cancer Institute.

[39]  A. Efstratiadis,et al.  Parental imprinting of the mouse insulin-like growth factor II gene , 1991, Cell.

[40]  B. Cattanach,et al.  Autosomal and X-chromosome imprinting. , 1990, Development (Cambridge, England). Supplement.

[41]  M. Surani,et al.  Developmental consequences of imprinting of parental chromosomes by DNA methylation. , 1990, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[42]  J. Minna,et al.  Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro. , 1988, The Journal of clinical investigation.

[43]  P. Leder,et al.  Parental legacy determines methylation and expression of an autosomal transgene: A molecular mechanism for parental imprinting , 1987, Cell.

[44]  Alastair,et al.  Developmental regulation of insulin-like growth factor II mRNA in different rat tissues. , 1986, The Journal of biological chemistry.

[45]  M. Surani,et al.  Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis , 1984, Nature.

[46]  J. Foekens,et al.  Loss of imprinting of IGF 2 and not H 19 in breast cancer , adjacent normal tissue and derived ¢ broblast cultures , 1998 .

[47]  M. Bartolomei,et al.  Genomic imprinting in mammals. , 1997, Annual review of genetics.

[48]  D. Barlow,et al.  Characteristics of imprinted genes , 1995, Nature Genetics.

[49]  M. Surani,et al.  Genomic imprinting and cancer. , 1995, Cancer surveys.

[50]  C. Sapienza,et al.  Imprinting the genome: imprinted genes, imprinting genes, and a hypothesis for their interaction. , 1993, Annual review of genetics.

[51]  D. Solter.  Differential imprinting and expression of maternal and paternal genomes. , 1988, Annual review of genetics.

[52]  W. W. Nichols,et al.  Genetic mechanisms of tumor-specific loss of 11p DNA sequences in Wilms tumor. , 1987, American journal of human genetics.